Results 201 to 210 of about 268,028 (214)

Antibody-Dependent Cellular Cytotoxicity of iPS Cell-Derived Natural Killer T Cells by Anti-GD2 mAb for Neuroblastoma. [PDF]

Cancer Sci
Nishimura K, Aoki T, Kobayashi M, Takami M, Ozaki K, Ogawa K, Hongxuan W, Shimizu D, Katsumi D, Yoshizawa H, Komatsu S, Takatani T, Hirahara K, Koseki H, Hishiki T, Motohashi S.   +15 more
europepmc   +1 more source

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine.

Eur J Cancer
Langenberg KPS, van Hooff SR, Koopmans B, Strijker JGM, Kholosy WM, Ober K, Zwijnenburg DA, van der Hoek JJF, Keller KM, Vernooij L, Schild LG, Looze EJ, Ebus ME, Essing AHW, Vree P, Tas ML, Matser YAH, Wienke J, Volckmann R, Tops BBJ, Kester LA, Badloe S, Hehir-Kwa JY, Kemmeren P, Goemans BF, Zwaan CM, Oehme I, Jäger N, Witt O, van Eijkelenburg NKA, Dierselhuis MP, Tytgat GAM, Wijnen MHW, van Noesel MM, de Krijger RR, Eising S, Koster J, Dolman EM, Molenaar JJ.   +38 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma.

New England Journal of Medicine, 2023
BACKGROUND Immunotherapy with chimeric antigen receptor (CAR)-expressing T cells that target the disialoganglioside GD2 expressed on tumor cells may be a therapeutic option for patients with high-risk neuroblastoma.
F. del Bufalo, B. De Angelis, Ignazio Caruana, G. Del Baldo, M. A. De Ioris, Annalisa Serra, A. Mastronuzzi, M. Cefalo, D. Pagliara, Matteo Amicucci, G. Li Pira, Giovanna Leone, V. Bertaina, M. Sinibaldi, S. Di Cecca, M. Guercio, Z. Abbaszadeh, Laura Iaffaldano, M. Gunetti, S. Iacovelli, Rossana Bugianesi, S. Macchia, M. Algeri, P. Merli, F. Galaverna, Rachid Abbas, M. Garganese, M. F. Villani, G. Colafati, F. Bonetti, M. Rabusin, K. Perruccio, Veronica Folsi, C. Quintarelli, F. Locatelli   +34 more
semanticscholar   +1 more source

Neuroblastoma

Definitions, 2018
Neuroblastoma is a type of cancer that most often affects children. Neuroblastoma occurs when immature nerve cells called neuroblasts become abnormal and multiply uncontrollably to form a tumor.
S. Jason, Foster Jennifer, 王曼, 扈玉华   +3 more
semanticscholar   +1 more source

Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.

Progress in clinical and biological research, 1993
PURPOSE AND METHODS: Based on preliminary experience, there was a need for modifications and clarifications in the International Neuroblastoma Staging System (INSS) and International Neuroblastoma Response Criteria (INRC). In 1988, a proposal was made to
G. Brodeur, J. Pritchard, F. Berthold, N. Carlsen, V. Castel, R. P. Castelberry, B. Bernardi, A. Evans, M. Favrot, F. Hedborg   +9 more
semanticscholar   +1 more source

Updates in Diagnosis, Management, and Treatment of Neuroblastoma.

Radiographics, 2018
Neuroblastoma is an embryonic tumor of the peripheral sympathetic nervous system. It is the most common extracranial solid tumor of childhood and accounts for up to 15% of all pediatric cancer fatalities.
C. Swift, Meryle J. Eklund, J. Kraveka, A. Alazraki   +3 more
semanticscholar   +1 more source

Advancing therapy for neuroblastoma

Nature Reviews Clinical Oncology, 2022
B. Qiu, K. Matthay
semanticscholar   +1 more source

Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma

Nature Genetics, 2021
Selina Jansky, A. Sharma, Verena Körber, Andrés Quintero, U. Toprak, Elisa M Wecht, Moritz Gartlgruber, A. Greco, Elad Chomsky, T. G. Grünewald, K. Henrich, A. Tanay, C. Herrmann, T. Höfer, F. Westermann   +14 more
semanticscholar   +1 more source

Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells.

European Review for Medical and Pharmacological Sciences, 2018
OBJECTIVE Ferroptosis is a new-found iron-dependent form of non-apoptotic regulated cell death (RCD), which is activated on therapy with several antitumor agents, but the potential mechanism remains unclear.
N. Geng, Bao-jun Shi, S-L Li, Zhining Zhong, Y-C Li, Wei Xua, H. Zhou, J. Cai   +7 more
semanticscholar   +1 more source

Abstract PR06: TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors

, 2016
Recently, we have presented the genomic landscape of 87 neuroblastoma tumors. This cohort has been extended to include 108 tumor/normal pairs of all INSS stages.
J. Koster, L. Valentijn, Danny Zwijnenburg, Nancy E. Hasselt, P. Sluis, M. Noesel, R. George, G. Tytgat, J. Molenaar, R. Versteeg   +9 more
semanticscholar   +1 more source